首页> 美国卫生研究院文献>BMC Psychiatry >Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial
【2h】

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

机译:褪黑激素与安慰剂联合治疗在苯二氮卓类药物逐渐减量期间的昼夜活动节律:数据来自于一项随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPatients with severe mental illness often suffer from disruptions in circadian rest-activity cycles, which might partly be attributed to ongoing psychopharmacological medication. Benzodiazepines are frequently prescribed for prolonged periods despite recommendations of only short-term usage. Melatonin, a naturally occurring nocturnal hormone, has the potential to stabilize disrupted circadian rhythmicity. Our aim was to investigate how prolonged-release melatonin affects rest-activity patterns in medicated patients with severe mental illness and if benzodiazepine dose reduction is associated with changes in circadian rhythm parameters.
机译:背景患有严重精神疾病的患者通常会遭受昼夜活动活动周期的中断,这可能部分归因于正在进行的心理药物治疗。尽管建议仅短期使用,但经常会长期开处方苯二氮卓类药物。褪黑素是一种自然发生的夜间激素,具有稳定被破坏的昼夜节律的潜力。我们的目的是研究褪黑激素的缓释如何影响严重精神病患者的静息活动模式,以及苯二氮卓剂量的减少是否与昼夜节律参数的改变有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号